The Norwegian Prednisolone in Early Psychosis Study
Last updated on July 2021Recruitment
- Recruitment Status
- Recruiting
- Estimated Enrollment
- Same as current
Summary
- Conditions
- Cognitive Change
- Immune Suppression
- Psychosis
- Schizophrenia and Related Disorders
- Type
- Interventional
- Phase
- Phase 2
- Design
- Allocation: RandomizedIntervention Model: Parallel AssignmentIntervention Model Description: Placebo-controlled randomized 1:1 comparison.Masking: Quadruple (Participant, Care Provider, Investigator, Outcomes Assessor)Primary Purpose: Treatment
Participation Requirements
- Age
- Between 18 years and 70 years
- Gender
- Both males and females
Description
Not Provided
Not Provided
Tracking Information
- NCT #
- NCT03340909
- Collaborators
- Helse Stavanger HF
- St. Olavs Hospital
- Investigators
- Principal Investigator: Erik Johnsen, MD, PhD Haukeland University Hospital Principal Investigator: Solveig Klæbo Reitan, MD, PhD St. Olavs Hospital Principal Investigator: Helle Schøyen, MD, PhD Helse Stavanger HF